"At Oak HC/FT, we’re passionate about deploying our collective skills to address important issues in the multi-trillion-dollar Healthcare and FinTech markets. We back innovative companies who are leveraging technology to improve quality, reduce inefficiencies and enhance customer experiences."
Andrew Adams (HC) is a Co-Founder and Managing Partner of Oak HC/FT where he focuses on growth equity and early-stage venture opportunities in Healthcare.
Andrew currently serves on the Boards of Galileo, Limeade, Paladina Health, Therapy Brands, US HealthVest and WithMe Health. He is also a Board Observer at Sema4. Andrew is also actively involved with Independent Living Systems, One Medical Group and Precision Medicine Group.
Prior investments include American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), CLARiENT (acquired by GE Healthcare), Core Informatics (acquired by Thermo Fischer Scientific), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly), LDI (acquired by Diplomat Pharmacy), Maestro Health (acquired by AXA Group), NetSpend Corporation (acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by CD&R) and United BioSource (acquired by Medco Health Solutions).
Andrew also serves as a General Partner of Oak Investment Partners which he joined in 2003. Prior to joining Oak Investment Partners, Andrew was a Senior Associate with Capital Resource Partners, a mezzanine capital firm where he focused on investments in healthcare and business services companies. Andrew was also a Financial Analyst in the media and communications group of Deutsche Banc Alex. Brown.
Andrew received a Bachelor of Arts degree from Princeton University.
Any small, remote beach.
“Here I Go Again” by Whitesnake
“Shoe Dog: A Memoir by the Creator of Nike” by Phil Knight
Alvin, Texas (home of Nolan Ryan)